Pharmatalkradio

In this session, panelists share challenges and new initiatives to support building the clinical researcher workforce, workforce planning and flexibility. They address: Efforts to train new clinical researchersMaintaining a remote vs in office hybrid work environment to allow for work/home life balance strategies to reduce churn Speakers: Suzanne Rose, MS, PhD, CCRC, FACRP, Executive Director of Research, Stamford HospitalBrian Sevier, PhD, Sr. Assoc. Director of Research Operations, Yale Center for Clinical InvestigationJennifer Sheller, MPH, Associate Vice President – Global Clinical Trial Operations, MerckSusan Landis, Executive Director, ACRP

In this fireside discussion, Josh Silverman shares the story of how Etsy built a platform to connect sellers and consumers to diverse, local and global communities and the impact on equal access and the democratization of talent. He shares some practical ideas the clinical research industry can integrate to do the same. Speakers: Josh Silverman, CEO, EtsyJohn Potthoff, PhD, CEO, Elligo Health Research

In this session recorded at CRAACO 2022, Dr Byrd shares insights on how to provide a wider offering of clinical research options to diverse populations by developing workstreams and policies addressing upstream issues including clinical researcher and physician outreach and systemic blockers that prevent DE&I. Speaker: Goldie Smith Byrd, PhD, Professor of Public Health Sciences & Director of the Maya Angelou Center for Health Equity, Wake Forest School of Medicine

In this podcast, you will hear a presentation from Dr Robert Garmise, Bristol-Myers Squibb, and Dr Paul Reichert, Merck, from the 2022 PODD Conference regarding developing molecules in space to benefit subcutaneous drug delivery including case studies of work done in the International Space Station, the potential of crystalline suspensions and future opportunities. To learn more about the PODD Conference, please visit PODDConference.com.  

In this fireside chat recorded at CMO Summit 2022, Drs Alise Reicin and Marcella Ruddy discuss what makes their collaboration work and advice on what not to do as an MD CEO and CMO. Speakers: Alise Reicin, MD, CEO & President, Tectonic TherapeuticMarcella Ruddy, MD, CMO, Tectonic Therapeutic

Community engagement is a massive challenge when it comes to diversity, equity and inclusion. This session will evaluate what has not worked and focus on the learnings so pharma/biotech can more successfully engage with under-represented communities long term. Key topics include:  How can pharma have more of a presence in the community and what does that mean to patients?What are the best ways to build trust and gain community insights from patients where studies are implemented?What will lead patients to embrace it and utilize it and make this whole effort more sustainable?What does community engagement look like for different stakeholders (patients, advocacy, pharma)?What are those institutions that might already be there that can be built upon?How have community centers of excellence been able to recruit racial, ethnic minority populations to successfully get input into studies? Moderated by: Adrelia Allen, PharmD, Director, Clinical Trial Patient Diversity, Global Clinical Trial Operations, Merck Researc

In this podcast, you will hear a presentation from Kurt Sedo of PharmaCircle at the 2022 PODD Conference summarizing trends, approvals and pipelines within the drug delivery space. To learn more about the PODD Conference, please visit PODDConference.com.  

Craig Davenport, Senior Director, Site Engagement, Eli Lilly Moderated by: Marilyn Metcalf, PhD, Senior Director, Patient-Focused Development, Global Medical, GSK Learn more about the Patients as Partners in Clinical Research conference at www.patientsaspartners.org

In this podcast, you will hear a panel discussion moderated by John Merhige, Credence MedSystems from the 2022 PODD Conference regarding implementable guidance for both pharma companies and delivery companies looking to partner including: The similarities and differences when collaborating on device vs. formulation delivery technologiesDifferent pathways and mechanisms available for different stages of innovative technology, from pure innovation to proven technologiesKey criteria Pharma is looking for in the technology and the innovator company AND advice on how to present to PharmaThe roles of procurement, business development and other functional groups in scoping, structuring deals and negotiation Panelists include: Deborah Bitterfield, PhD, Lindy BiosciencesMichael Cucolo, Bristol-Myers SquibbVincent Ling, PhD, TakedaSarah Tao, PhD, Sanofi Partnering To learn more about the PODD Conference, please visit PODDConference.com.  

We are honored to open Patients as Partners with Karen Peterson, patient #1 in a metastatic triple-negative breast cancer immunotherapy combination trial at NYU Langone Cancer Center. In this fireside chat, she provides personal insights on her trial journey, which has led her to her advocacy work to raise clinical trial education and awareness in underrepresented communities. Karen Peterson, Patient Advocate, Karen's ClubDeirdre BeVard, R&D Strategic Operations, CSL Behring Learn more about the Patients as Partners in Clinical Research conference at www.patientsaspartners.org

As each CMO role is different, it is critical for both first-time and seasoned CMOs to identify the role and develop a plan to ensure a successful transition. In this session recorded at CMO Summit 2021, panelists explore: What to look for in a companyIdentifying the position and taking your placePrioritizing responsibilities and first hires Speakers: Laurie Halloran, BSN, MS, President & CEO, Halloran Consulting Group, IncJames “Terry” Ferguson, MD, CMO, Matinas BiopharmaBecker Hewes, MD, CMO, Blueprint MedicinesRoger Waltzman, MD, MBA, CMO, Molecular Templates

Dr Viney joine the CMO Summit 360° in 2021 to share her incredible journey in drug discovery and development, founding and leading Pandion Therapeutics and joining the advisory boards of multiple biotech companies. Speakers: Jo Viney, PhD, President and CEO, Seismic TherapeuticZain Kassam, MD, MPH, Co-Founder, CMO, Finch Therapeutics

In this session recorded at CMO Summit 2021, hear from Dr Ron Cohen about his journey founding and building Acorda Therapeutics and leading the company as an MD CEO for 26 years. Dr Cohen also shares advice on how CMOs can best collaborate with their CEOs and add value to their companies. Speakers: Ron Cohen, MD, Founder, President & CEO, Acorda TherapeuticsKen Getz, MBA, Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine /Founder and Board Chair, CISCRP

It is vital for the CMO to have excellent communication awareness and skills to communicate externally with KOLs, investors, the scientific community and more. In this session, recorded at CMO Summit 2022, seasoned CMOs share their best practices and more specifically: How to sell a science story to scientists and non-scientists alikePreparing for and managing negative outcomes and weak signalsAligning communications from the CMO, CEO and Commercial Speakers: Cadmus Rich, MD, MBA, CMO & Head of R&D, Aura BiosciencesStephen Huhn, MD, CMO & SVP of Clinical Development, Pipeline TherapeuticsAnna Berkenblit, MD, MMSc, SVP, CMO, ImmunoGenMargaret Koziel, MD, SVP, CMO, Axcella

In this podcast, you will hear a zeitgeist fireside discussion with Dr Nicholas Warne, Pfizer, from the 2022 PODD Conference regarding what the drug delivery industry learned from COVID-19, his view of RNA and LNP technologies, and building on therapies with applications across oncology, rare disease and chronic disease. To learn more about the PODD Conference, please visit PODDConference.com.  

This session recorded at CMO Summit 2022 addresses the role of the CMO in how to best manage the relationship between your biotech and big pharma. More specifically: What are the leadership skills needed?Where are the friction points and how do you avoid them or fix them? Speakers: Joanne Lager, MD, CMO, iTeos TherapeuticsThomas Davis, MD, CMO, Genocea BiosciencesMilan Zdravkovic, MD, PhD, CMO, SNIPR BiomeEric Crombez, MD, CMO, Gene Therapy & Inborn Errors of Metabolism, Ultragenyx

Pfizer’s VP, Patient Advocacy, Emma Andrews, joins Patients as Partners US to provide her insights on the following: Internal and external collaborations to advance patient-focused programs across the enterprise Patient centricity within clinical trial design, research and development, and health equity efforts Pfizer’s deep focus on health literacy Emma Andrews, PharmD, VP, Global Patient Advocacy, Pfizer Cindy Geoghegan, Patient Advocate Learn more about the Patients as Partners in Clinical Research conference at www.patientsaspartners.org

In this session recorded at CMO Summit 2022, panelists share strategy trends and opportunities around accelerated approvals and regulatory designations. Additionally, they discuss: How to approach the FDA based on the different types of meetingsHow these trends and pathways affect trial designImplications after approval based on the pathway Speakers: Edith Perez, MD, CMO, Bolt BiotherapeuticsJeffrey Bornstein, MD, CMO, Eledon PharmaceuticalsAmy Blawas, PhD, Principal Consultant, NDA Group

In this session recorded at CMO Summit 2022, the panel discusses: What CMOs need to know about series funding, crossover and IPOHow to think about when to engage in these financing options based on the company stage, milestones, and budgetHow CMOs can best support the decision-making and fundraising processes Speakers: Nerissa Kreher, MD, MBA, CMO, Entrada TherapeuticsGeoff Meyerson, MBA, Co-Founder & CEO, Locust WalkTariq Kassum, MD, CEO, Celsius TherapeuticsAnn Barbier, MD, PhD, CMO, CAMP4 Therapeutics

In this session recorded at CMO Summit 2022, Board members share their experiences and discuss how CMOs can think about Board role opportunities including: Knowing why you want a seat on a Board and what you bring to the tableThe skills needed to succeed and excel in the role of development representation on a Board, both private & publicWorking with your current CEO and Board while advising another companyIdentifying the reality of what you are getting into Speakers: Julie Hambleton, MD, Biotech Executive & Independent Board Member, Public and Private Biotech CompaniesAoife Brennan, MB, BCh, BAO, MRCPI, CEO, SynlogicHolly Schachner, MD, CMO, Double Rainbow BiosciencesJeffrey Humphrey, MD, CMO, Magenta Therapeutics